MAK (Ab-159) Antibody

What is MAK (Ab-159) Antibody and what is its target protein?

MAK (Ab-159) Antibody is a polyclonal antibody that specifically recognizes and binds to the male germ cell-associated kinase (MAK) protein. MAK is a serine/threonine protein kinase (EC 2.7.11.22) involved in signal transduction pathways. The antibody is designed to detect endogenous levels of total MAK protein .

The target protein, MAK, has the following characteristics:

• UniProtID: P20794

• Molecular Weight: Approximately 66,345 Da or 70kDa (observed)

• Aliases: Male germ cell-associated kinase, Serine/threonine-protein kinase MAK, RP62, dJ417M14.2

• Research Areas: Signal Transduction

What are the validated applications for MAK (Ab-159) Antibody?

The MAK (Ab-159) Antibody has been validated for specific research applications with recommended dilutions:

The antibody has been specifically optimized for Western blotting applications, where it can detect endogenous levels of total MAK protein . Scientific validation data shows successful detection of MAK in extracts from K562 cells .

What are the physical and biochemical properties of MAK (Ab-159) Antibody?

The MAK (Ab-159) Antibody has the following key properties:

These properties determine the antibody's binding characteristics and stability in various experimental conditions .

How should MAK (Ab-159) Antibody be stored and handled for optimal performance?

Proper storage and handling are crucial for maintaining antibody activity:

• Upon receipt, store at -20°C or -80°C

• Avoid repeated freeze-thaw cycles to prevent degradation of the antibody

• When working with the antibody, keep it on ice

• For long-term storage, consider making small aliquots to minimize freeze-thaw cycles

• The inclusion of 50% glycerol in the formulation helps maintain stability during freeze-thaw cycles

• Before use, centrifuge the antibody vial briefly to ensure collection of all material

These storage recommendations help preserve antibody activity and specificity for extended periods.

What species reactivity has been confirmed for MAK (Ab-159) Antibody?

The species reactivity of MAK (Ab-159) Antibody varies based on the supplier. Different versions of this antibody show the following reactivity patterns:

When planning cross-species experiments, researchers should verify reactivity claims with the specific supplier and consider performing validation experiments in their model system of interest .

How does MAK (Ab-159) Antibody differ from phospho-specific MAK antibodies?

There are important functional differences between the total protein-detecting MAK (Ab-159) Antibody and phospho-specific alternatives:

For comprehensive signaling pathway studies, researchers often use both antibody types in parallel - the phospho-specific antibody to detect activated MAK and the total protein antibody (like MAK Ab-159) to normalize for total protein expression levels .

What experimental design considerations are important when using MAK (Ab-159) Antibody in Western blotting?

For optimal Western blotting with MAK (Ab-159) Antibody, consider these methodological aspects:

• Sample Preparation:

  • Use appropriate lysis buffers with protease inhibitors

  • Denature samples completely at 95-100°C for 5 minutes in reducing sample buffer

  • Load equal amounts of protein (15-30μg) per lane

• Gel Selection and Transfer:

  • Use 10-12% SDS-PAGE gels given MAK's molecular weight (approximately 70kDa)

  • Ensure complete transfer to PVDF or nitrocellulose membrane

• Blocking and Antibody Incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Use MAK (Ab-159) Antibody at 1:500-1:3000 dilution

  • Incubate with primary antibody overnight at 4°C

• Controls and Validation:

  • Include positive control lysates (e.g., K562 cells shown to express MAK)

  • Consider siRNA/shRNA knockdown controls to validate specificity

  • Use appropriate HRP-conjugated secondary antibody against rabbit IgG

• Detection and Analysis:

  • Develop using enhanced chemiluminescence (ECL) substrates

  • Quantify band intensity relative to loading controls

This experimental design helps ensure specific detection and accurate quantification of MAK protein levels .

How can researchers validate the specificity of MAK (Ab-159) Antibody for their particular experimental system?

• Genetic Approaches:

  • Compare signals in wild-type versus MAK knockout/knockdown samples

  • Overexpress MAK in low-expressing cell lines to confirm band identity

  • Use CRISPR-Cas9 to generate MAK-deficient controls

• Biochemical Validation:

  • Perform immunoprecipitation followed by mass spectrometry

  • Confirm molecular weight matches predicted size for MAK (~70kDa)

  • Compete binding with immunizing peptide when available

• Cross-Platform Confirmation:

  • Compare results with alternative MAK antibodies targeting different epitopes

  • Correlate protein detection with mRNA expression data

  • Use orthogonal methods like mass spectrometry to confirm presence of MAK

• Controls in Experimental Setting:

  • Include tissue/cells known to express or lack MAK expression

  • Test antibody performance in different sample preparation conditions

Systematic validation ensures experimental observations reflect true MAK biology rather than antibody artifacts .

What are the considerations for using MAK (Ab-159) Antibody in single-subject experimental design studies?

When utilizing MAK (Ab-159) Antibody in single-subject experimental designs (SSEDs), researchers should address these methodological considerations:

These considerations help maximize internal and external validity when using MAK (Ab-159) Antibody in single-subject research designs .

How can researchers interpret conflicting results when using MAK (Ab-159) Antibody alongside structural analysis techniques?

When integrating antibody-based detection with structural analysis, conflicting results may emerge. To resolve these discrepancies:

• Understanding Method Limitations:

  • Recognize that antibodies detect specific epitopes while structural methods provide holistic protein information

  • MAK (Ab-159) Antibody targets a specific internal epitope that may be inaccessible in certain protein conformations

  • Consider that computational predictions (e.g., AlphaFold Multimer) sometimes fail to accurately model antibody-antigen interactions

• Complementary Approaches:

  • Use X-ray crystallography to definitively determine epitope-antibody interactions

  • Compare experimental structures with computational predictions

  • Implement multiple detection methods targeting different MAK regions

• Reconciliation Strategies:

  • Test whether sample preparation affects epitope accessibility (native vs. denatured conditions)

  • Identify potential post-translational modifications that might affect antibody recognition

  • Consider protein-protein interactions that could mask epitopes

• Integrated Analysis:

  • Develop a concordance model that accommodates both structural and immunological data

  • Weight evidence based on methodological strengths of each approach

  • Document methodological differences that might explain discrepancies

As demonstrated in structural immunology studies, experimental validation remains essential even as computational methods advance .

What are the critical considerations when using MAK (Ab-159) Antibody in combination with other antibodies for co-localization studies?

When designing co-localization experiments with MAK (Ab-159) Antibody and other antibodies:

• Antibody Compatibility:

  • Ensure primary antibodies are raised in different host species to avoid cross-reactivity of secondary antibodies

  • If using multiple rabbit antibodies, consider direct conjugation or sequential staining protocols

  • Test for potential cross-reactivity between antibodies in control experiments

• Optimizing Multiplex Detection:

  • Titrate each antibody individually before combining in multiplex assays

  • Consider the use of Fab fragments or monovalent antibodies to reduce steric hindrance

  • Validate signal specificity with appropriate controls (single stain, secondary-only, blocking peptides)

• Technical Considerations:

  • Select fluorophores with minimal spectral overlap

  • Account for potential differences in fixation/permeabilization requirements

  • Implement appropriate antigen retrieval methods if needed

• Analysis Approaches:

  • Use quantitative co-localization metrics (Pearson's coefficient, Manders' coefficient)

  • Implement appropriate thresholding methods

  • Consider 3D analysis when appropriate

These considerations help ensure valid interpretation of co-localization data between MAK and other proteins of interest .

How does the MAK (Ab-159) Antibody compare to other MAK antibodies in therapeutic antibody development research?

While MAK (Ab-159) Antibody is primarily a research tool rather than a therapeutic candidate, understanding its properties in comparison to therapeutic antibodies provides valuable insights:

• Structural Considerations:

  • Research-grade polyclonal antibodies like MAK (Ab-159) contain heterogeneous antibody populations

  • Therapeutic antibodies require monoclonal production with defined epitope binding

  • MAK (Ab-159)'s rabbit IgG isotype differs from therapeutic human(ized) antibodies

• Fc-Mediated Functions:

  • Different IgG subclasses exhibit varying effector functions

  • Therapeutic antibodies are engineered with specific Fc regions (e.g., LALA mutations) to modulate effector functions

  • Research antibodies like MAK (Ab-159) have not been optimized for in vivo activity

• Methodological Applications:

  • MAK (Ab-159) serves as a detection tool in model systems studying antibody-antigen interactions

  • Can be used to validate epitope accessibility in developing therapeutic candidates

  • Helps establish expression patterns of target proteins in disease models

• Development Pipeline Integration:

  • Research antibodies provide preliminary target validation

  • Structural insights from research antibodies inform therapeutic antibody design

  • Epitope mapping with research antibodies guides optimization of therapeutic candidates

This comparison highlights how research antibodies like MAK (Ab-159) contribute to the broader therapeutic antibody development process .